Konstantinos (Kostas) K Tsilidis

Konstantinos (Kostas) K Tsilidis

University of Ioannina

H-index: 66

Europe-Greece

About Konstantinos (Kostas) K Tsilidis

Konstantinos (Kostas) K Tsilidis, With an exceptional h-index of 66 and a recent h-index of 54 (since 2020), a distinguished researcher at University of Ioannina, specializes in the field of Cancer Epidemiology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Leisure time television watching, computer use and risks of breast, colorectal and prostate cancer: A Mendelian randomisation analysis

Post-diagnosis physical activity and sedentary behaviour and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta …

Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis

Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk

Difference on glucose profile from continuous glucose monitoring in people with prediabetes vs. normoglycemic individuals: a matched-pair analysis

Interactions of obesity, body shape, diabetes and sex steroids with respect to prostate cancer risk in the UK Biobank cohort

Allometric versus traditional body-shape indices and risk of colorectal cancer: a Mendelian randomization analysis

Novel genetic loci, lifestyle factors, and inflammatory markers identified as risk factors for sarcoidosis

Konstantinos (Kostas) K Tsilidis Information

University

University of Ioannina

Position

Associate Professor of Epidemiology Department of Hygiene and Epidemiology

Citations(all)

16167

Citations(since 2020)

11364

Cited By

8183

hIndex(all)

66

hIndex(since 2020)

54

i10Index(all)

211

i10Index(since 2020)

201

Email

University Profile Page

University of Ioannina

Konstantinos (Kostas) K Tsilidis Skills & Research Interests

Cancer Epidemiology

Top articles of Konstantinos (Kostas) K Tsilidis

Leisure time television watching, computer use and risks of breast, colorectal and prostate cancer: A Mendelian randomisation analysis

Authors

Nikos Papadimitriou,Nabila Kazmi,Niki Dimou,Konstantinos K Tsilidis,Richard M Martin,Sarah J Lewis,Brigid M Lynch,Michael Hoffmeister,Sun‐Seog Kweon,Li Li,Roger L Milne,Lori C Sakoda,Robert E Schoen,Amanda I Phipps,Jane C Figueiredo,Ulrike Peters,Suzanne C Dixon‐Suen,Marc J Gunter,Neil Murphy

Journal

Cancer Medicine

Published Date

2024/1

Background Sedentary behaviours have been associated with increased risks of some common cancers in epidemiological studies; however, it is unclear if these associations are causal. Methods We used univariable and multivariable two‐sample Mendelian randomisation (MR) to examine potential causal relationships between sedentary behaviours and risks of breast, colorectal and prostate cancer. Genetic variants associated with self‐reported leisure television watching and computer use were identified from a recent genome‐wide association study (GWAS). Data related to cancer risk were obtained from cancer GWAS consortia. A series of sensitivity analyses were applied to examine the robustness of the results to the presence of confounding. Results A 1‐standard deviation (SD: 1.5 h/day) increment in hours of television watching increased risk of breast cancer (OR per 1‐SD: 1.15, 95% confidence …

Post-diagnosis physical activity and sedentary behaviour and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta …

Authors

G Markozannes,N Becerra-Tomás,M Cariolou,K Balducci,AR Vieira,S Kiss,D Aune,DC Greenwood,MJ Gunter,E Copson,AG Renehan,M Bours,W Demark-Wahnefried,M Hudson,AM May,FT Odedina,R Skinner,K Steindorf,A Tjonneland,G Velikova,ML Baskin,R Chowdhury,L Hill,S Lewis,J Seidell,M Weijenberg,J Krebs,A Cross,K Tsilidis,D Chan

Published Date

2024/1/17

Post-diagnosis physical activity and sedentary behaviour and colorectal cancer prognosis: a Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis - White Rose Research Online White Rose logo White Rose Research Online Home Search Browse Contact Post-diagnosis physical activity and sedentary behaviour and colorectal cancer prognosis: a Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis Markozannes, G., Becerra-Tomás, N., Cariolou, M. et al. (27 more authors) (Accepted: 2024) Post-diagnosis physical activity and sedentary behaviour and colorectal cancer prognosis: a Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis. International Journal of Cancer. ISSN 0020-7136 (In Press) Metadata Authors/Creators: Markozannes, G. Becerra-Tomás, N. Cariolou, M. Balducci, K. …

Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis

Authors

James Yarmolinsky,Jamie W Robinson,Daniela Mariosa,Ville Karhunen,Jian Huang,Niki Dimou,Neil Murphy,Kimberley Burrows,Emmanouil Bouras,Karl Smith-Byrne,Sarah J Lewis,Tessel E Galesloot,Lambertus A Kiemeney,Sita Vermeulen,Paul Martin,Demetrius Albanes,Lifang Hou,Polly A Newcomb,Emily White,Alicja Wolk,Anna H Wu,Loïc Le Marchand,Amanda I Phipps,Daniel D Buchanan,Maria Teresa Landi,Victoria Stevens,Ying Wang,Demetrios Albanes,Neil Caporaso,Paul Brennan,Christopher I Amos,Sanjay Shete,Rayjean J Hung,Heike Bickeböller,Angela Risch,Richard Houlston,Stephen Lam,Adonina Tardon,Chu Chen,Stig E Bojesen,Mattias Johansson,H-Erich Wichmann,David Christiani,Gadi Rennert,Susanne Arnold,John K Field,Loic Le Marchand,Olle Melander,Hans Brunnström,Geoffrey Liu,Angeline Andrew,Hongbing Shen,Shan Zienolddiny,Kjell Grankvist,Mikael Johansson,M Dawn Teare,Yun-Chul Hong,Jian-Min Yuan,Philip Lazarus,Matthew B Schabath,Melinda C Aldrich,Rosalind A Eeles,Christopher A Haiman,Zsofia Kote-Jarai,Fredrick R Schumacher,Sara Benlloch,Ali Amin Al Olama,Kenneth R Muir,Sonja I Berndt,David V Conti,Fredrik Wiklund,Stephen Chanock,Catherine M Tangen,Jyotsna Batra,Judith A Clements,Henrik Grönberg,Nora Pashayan,Johanna Schleutker,Stephanie J Weinstein,Catharine ML West,Lorelei A Mucci,Géraldine Cancel-Tassin,Stella Koutros,Karina Dalsgaard Sørensen,Eli Marie Grindedal,David E Neal,Freddie C Hamdy,Jenny L Donovan,Ruth C Travis,Robert J Hamilton,Sue Ann Ingles,Barry S Rosenstein,Yong-Jie Lu,Graham G Giles,Robert J MacInnis,Adam S Kibel,Ana Vega,Manolis Kogevinas,Kathryn L Penney,Jong Y Park,Janet L Stanfrod,Cezary Cybulski,Børge G Nordestgaard,Sune F Nielsen,Hermann Brenner,Christiane Maier,Christopher J Logothetis,Esther M John,Manuel R Teixeira,Susan L Neuhausen,Kim De Ruyck,Azad Razack,Lisa F Newcomb,Davor Lessel,Radka Kaneva,Nawaid Usmani,Frank Claessens,Paul A Townsend,Jose Esteban Castelao,Monique J Roobol,Florence Menegaux,Kay-Tee Khaw,Lisa Cannon-Albright,Hardev Pandha,Stephen N Thibodeau,David J Hunter,Peter Kraft,William J Blot,Elio Riboli,Sizheng Steven Zhao,Dipender Gill,Stephen J Chanock,Mark P Purdue,George Davey Smith,Karl-Heinz Herzig,Marjo-Riitta Järvelin,Chris I Amos,Abbas Dehghan,Marc J Gunter,Kostas K Tsilidis,Richard M Martin

Journal

EBioMedicine

Published Date

2024/2/1

BackgroundTumour-promoting inflammation is a "hallmark" of cancer and conventional epidemiological studies have reported links between various inflammatory markers and cancer risk. The causal nature of these relationships and, thus, the suitability of these markers as intervention targets for cancer prevention is unclear.MethodsWe meta-analysed 6 genome-wide association studies of circulating inflammatory markers comprising 59,969 participants of European ancestry. We then used combined cis-Mendelian randomization and colocalisation analysis to evaluate the causal role of 66 circulating inflammatory markers in risk of 30 adult cancers in 338,294 cancer cases and up to 1,238,345 controls. Genetic instruments for inflammatory markers were constructed using genome-wide significant (P < 5.0 × 10−8) cis-acting SNPs (i.e., in or ±250 kb from the gene encoding the relevant protein) in weak linkage …

Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk

Authors

Yu Tian,Yi Lin,Conghui Qu,Volker Arndt,James W Baurley,Sonja I Berndt,Stephanie A Bien,D Timothy Bishop,Hermann Brenner,Daniel D Buchanan,Arif Budiarto,Peter T Campbell,Robert Carreras-Torres,Graham Casey,Andrew T Chan,Rui Chen,Xuechen Chen,David V Conti,Virginia Díez-Obrero,Niki Dimou,David A Drew,Jane C Figueiredo,Steven Gallinger,Graham G Giles,Stephen B Gruber,Marc J Gunter,Sophia Harlid,Tabitha A Harrison,Akihisa Hidaka,Michael Hoffmeister,Jeroen R Huyghe,Mark A Jenkins,Kristina M Jordahl,Amit D Joshi,Temitope O Keku,Eric Kawaguchi,Andre E Kim,Anshul Kundaje,Susanna C Larsson,Loic Le Marchand,Juan Pablo Lewinger,Li Li,Victor Moreno,John Morrison,Neil Murphy,Hongmei Nan,Rami Nassir,Polly A Newcomb,Mireia Obón-Santacana,Shuji Ogino,Jennifer Ose,Bens Pardamean,Andrew J Pellatt,Anita R Peoples,Elizabeth A Platz,John D Potter,Ross L Prentice,Gad Rennert,Edward A Ruiz-Narvaez,Lori C Sakoda,Robert E Schoen,Anna Shcherbina,Mariana C Stern,Yu-Ru Su,Stephen N Thibodeau,Duncan C Thomas,Konstantinos K Tsilidis,Franzel JB van Duijnhoven,Bethany Van Guelpen,Kala Visvanathan,Emily White,Alicja Wolk,Michael O Woods,Anna H Wu,Ulrike Peters,W James Gauderman,Li Hsu,Jenny Chang-Claude

Journal

British journal of cancer

Published Date

2024/4/1

BackgroundMenopausal hormone therapy (MHT), a common treatment to relieve symptoms of menopause, is associated with a lower risk of colorectal cancer (CRC). To inform CRC risk prediction and MHT risk-benefit assessment, we aimed to evaluate the joint association of a polygenic risk score (PRS) for CRC and MHT on CRC risk.MethodsWe used data from 28,486 postmenopausal women (11,519 cases and 16,967 controls) of European descent. A PRS based on 141 CRC-associated genetic variants was modeled as a categorical variable in quartiles. Multiplicative interaction between PRS and MHT use was evaluated using logistic regression. Additive interaction was measured using the relative excess risk due to interaction (RERI). 30-year cumulative risks of CRC for 50-year-old women according to MHT use and PRS were calculated.ResultsThe reduction in odds ratios by MHT use was larger in women …

Difference on glucose profile from continuous glucose monitoring in people with prediabetes vs. normoglycemic individuals: a matched-pair analysis

Authors

Evangelos C Rizos,Afroditi Kanellopoulou,Panagiotis Filis,Georgios Markozannes,Konstantinos Chaliasos,Evangelia E Ntzani,Athina Tzamouranou,Nikolaos Tentolouris,Konstantinos K Tsilidis

Journal

Journal of Diabetes Science and Technology

Published Date

2024/3

IntroductionComprehensive characteristics of the glycemic profile for prediabetes derived by continuous glucose monitoring (CGM) are unknown. We evaluate the difference of CGM profiles between individuals with prediabetes and normoglycemic individuals, including the response to oral glucose tolerance test (OGTT).MethodsIndividuals with prediabetes matched for age, sex, and BMI with normoglycemic individuals were instructed to use professional CGM for 1 week. OGTT was performed on the second day. The primary outcomes were percentages of glucose readings time below range (TBR): <54 or <70 mg/dL, time in range (TIR): 70 to 180 mg/dL, and time above range (TAR): >180 or >250 mg/dL. Area under the curve (AUC) was calculated following the OGTT. Glucose variability was depicted by coefficient of variation (CV), SD, and mean amplitude of glucose excursion (MAGE). Wilcoxon sign-ranked test …

Interactions of obesity, body shape, diabetes and sex steroids with respect to prostate cancer risk in the UK Biobank cohort

Authors

Sofia Christakoudi,Konstantinos K Tsilidis,Evangelos Evangelou,Elio Riboli

Journal

Cancer Medicine

Published Date

2024/1/17

Background Obesity and diabetes are associated inversely with low‐grade prostate cancer risk and affect steroid hormone synthesis but whether they modify each other's impact on prostate cancer risk remains unknown. Methods We examined the independent associations of diabetes, body mass index (BMI), ‘a body shape index’ (ABSI), hip index (HI), circulating testosterone, sex hormone binding globulin (SHBG) (per one standard deviation increase) and oestradiol ≥175 pmol/L with total prostate cancer risk using multivariable Cox proportional hazards models for UK Biobank men. We evaluated multiplicative interactions (pMI) and additive interactions (relative excess risk from interaction (pRERI), attributable proportion (pAR), synergy index (pSI)) with obese (BMI ≥30 kg/m2) and diabetes. Results During a mean follow‐up of 10.3 years, 9417 incident prostate cancers were diagnosed in 195,813 men …

Allometric versus traditional body-shape indices and risk of colorectal cancer: a Mendelian randomization analysis

Authors

Marina O Rontogianni,Emmanouil Bouras,Elom Kouassivi Aglago,Heinz Freisling,Neil Murphy,Michelle Cotterchio,Jochen Hampe,Annika Lindblom,Rish K Pai,Paul DP Pharoah,Amanda I Phipps,Franzel JB van Duijnhoven,Kala Visvanathan,Bethany van Guelpen,Christopher I Li,Hermann Brenner,Andrew J Pellatt,Shuji Ogino,Marc J Gunter,Ulrike Peters,Sofia Christakoudi,Konstantinos K Tsilidis

Journal

International Journal of Obesity

Published Date

2024/1/31

BackgroundTraditional body-shape indices such as Waist Circumference (WC), Hip Circumference (HC), and Waist-to-Hip Ratio (WHR) are associated with colorectal cancer (CRC) risk, but are correlated with Body Mass Index (BMI), and adjustment for BMI introduces a strong correlation with height. Thus, new allometric indices have been developed, namely A Body Shape Index (ABSI), Hip Index (HI), and Waist-to-Hip Index (WHI), which are uncorrelated with weight and height; these have also been associated with CRC risk in observational studies, but information from Mendelian randomization (MR) studies is missing.MethodsWe used two-sample MR to examine potential causal cancer site- and sex-specific associations of the genetically-predicted allometric body-shape indices with CRC risk, and compared them with BMI-adjusted traditional body-shape indices, and BMI. Data were obtained from UK Biobank …

Novel genetic loci, lifestyle factors, and inflammatory markers identified as risk factors for sarcoidosis

Authors

Shuai Yuan,Jie Chen,Sizheng Steven Zhao,James Yarmolinsky,Elizabeth Arkema,Konstantinos Tsilidis,Stephen Burgess,Susanna Larsson

Published Date

2024/3/4

We carried out a genome-wide association and Mendelian randomization analysis to probe genetic and environmental risk factors for sarcoidosis. We performed a genome-wide meta-analysis in 5,194 sarcoidosis cases and 777,559 non-cases from the FinnGen and UK Biobank studies. We estimated the heritability, pinpointed genomic risk loci, predicted deleteriousness, mapped corresponding genes, and enriched gene expression to tissues using FUMA (Functional Mapping and Annotation) and MAGMA (Multi-marker Analysis of GenoMic Annotation) softwares. We performed Mendelian randomization analyses to investigate the links between 6 modifiable factors and 66 inflammatory markers in relation to sarcoidosis. Genetic variants associated with these exposures at the genome-wide significance level and in low linkage disequilibrium were used as instrumental variables. The heritability of sarcoidosis explained by common genetic variants was around 12%. We annotated 14 genomic loci that surpassed the genome-wide significance threshold of which 6 loci were previously unreported. The locus proximal to TYK2 had a high potential deleterious impact on protein function. MAGMA revealed notable gene expression patterns in whole blood, spleen, and lung. Genetically predicted lower levels of physical activity and higher levels of body mass index, interleukin-23 receptor, and interleukin 1 receptor-like 2 were associated with a heighted risk of sarcoidosis.

Evaluating the impact of pre‐diagnostic use of statins and testosterone replacement therapy on mortality outcomes in older men with hormone‐related cancers: Surveillance …

Authors

Maryam R Hussain,Omer Abdelgadir,Efstathia Polychronopoulou,Konstantinos K Tsilidis,Laith Alzweri,Alejandro Villasante‐Tezanos,Jacques Baillargeon,Steven Canfield,Yong‐Fang Kuo,David S Lopez

Journal

Andrology

Published Date

2024/2/29

Background The link between the pre‐diagnostic use of statins and testosterone replacement therapy and their impact on hormone‐related cancers, prostate cancer, colorectal cancer, and male breast cancer survival remains a topic of controversy. Further, there is a knowledge gap concerning the joint effects of statins and testosterone replacement therapy on hormone‐related cancer survival outcomes. Objective To examine the independent and joint effects of pre‐diagnostic use of statins and testosterone replacement therapy on the risk of all‐cause and cause‐specific mortality among older men diagnosed with hormone‐related cancers, including prostate cancer, colorectal cancer, and male breast cancer. Methods In 41,707 men (≥65 years) of Surveillance, Epidemiology, and End Results‐Medicare 2007–2015, we identified 31,097 prostate cancer, 10,315 colorectal cancer, and 295 male breast cancer …

Temporal trajectories of COVID-19 symptoms in adults with 22 months follow-up in a prospective cohort study in Norway.

Authors

Merete Ellingjord-Dale,Anders Nygaard,Nathalie Stoer,Ragnhild Boe,Nils Inge Landroe,Sonja Hjellegjerde Brunvoll,Mette Istre,Karl Trygve Kalleberg,John Arne Dahl,Linda Geng,Konstantinos Tsilidis,Elio Riboli,Giske Ursin,Arne Soeraas

Journal

medRxiv

Published Date

2024

Objectives We aimed to describe the trajectories of cognitive and physical symptoms before, during, and after a positive- or negative SARS-CoV-2 test and in untested controls. Design A prospective cohort study. Setting Norway, 27 March 2020 to 6 July 2022 Participants A total of 146 065 volunteers were recruited. Of these, 120 605 participants (mean age 49 (SD 13.7), 69% female), were initially untested for the SARS-CoV-2 virus, completed one or more follow-up questionnaires (response rates 72-90%) and were included for analysis. After 22 months of follow-up, 15 737 participants had a positive SARS-CoV-2 test, 67 305 a negative test, and 37 563 were still untested. Main outcome measures We assessed reported symptoms the past three weeks of memory or concentration problems, anosmia and dysgeusia, dyspnoea, fatigue, fever, headache, cough, muscular pain, nasal symptoms, sore throat and abdominal pain at baseline and through four follow-up questionnaires. In addition, overall health compared to a year before was measured with a five-point scale and memory problems were measured using the Everyday Memory Questionnaire-13 at two timepoints. The exposure, SARS-CoV-2 test status (positive, negative or untested), was obtained from a mandatory national registry or from self-report, and data were analysed using mixed model logistic regression. Results A positive SARS-CoV-2-test was associated with the following persistent symptoms, compared with participants with a negative test (1-3 months after a negative test); memory problems (3 to 6 months after a positive test: adjusted odds ratio (OR) 9.1, 95% confidence …

Post-diagnosis adiposity, physical activity, sedentary behaviour, dietary factors, supplement use and colorectal cancer prognosis: Global Cancer Update Programme (CUP Global …

Authors

K Tsilidis,G Markozannes,N Becerra-Tomás,M Cariolou,K Balducci,AR Vieira,S Kiss,D Aune,DC Greenwood,L Dossus,E Gonzalez Gil,MJ Gunter,K Allen,NT Brockton,H Croker,V Gordon-Dseagu,P Mitrou,N Musuwo,MJ Wiseman,E Copson,AG Renehan,M Bours,W Demark-Wahnefried,M Hudson,AM May,FT Odedina,R Skinner,K Steindorf,A Tjonneland,G Velikova,ML Baskin,R Chowdhury,L Hill,S Lewis,J Seidell,M Weijenberg,J Krebs,A Cross,D Chan

Journal

International Journal of Cancer

Published Date

2024/1/17

Post-diagnosis adiposity, physical activity, sedentary behaviour, dietary factors, supplement use and colorectal cancer prognosis: Global Cancer Update Programme (CUP Global) summary of evidence grading - White Rose Research Online White Rose logo White Rose Research Online Home Search Browse Contact Post-diagnosis adiposity, physical activity, sedentary behaviour, dietary factors, supplement use and colorectal cancer prognosis: Global Cancer Update Programme (CUP Global) summary of evidence grading Tsilidis, K., Markozannes, G., Becerra-Tomás, N. et al. (36 more authors) (Accepted: 2024) Post-diagnosis adiposity, physical activity, sedentary behaviour, dietary factors, supplement use and colorectal cancer prognosis: Global Cancer Update Programme (CUP Global) summary of evidence grading. International Journal of Cancer. ISSN 0020-7136 (In Press) Metadata Authors/Creators: Tsilidis, …

Sleep Quality and Cognitive Abilities in the Greek Cohort of Epirus Health Study

Authors

Myrto Koutsonida,Maria Psyhogiou,Eleni Aretouli,Konstantinos K Tsilidis

Journal

Nature and Science of Sleep

Published Date

2024/12/31

PurposeSleep is essential to all human body functions as well as brain functions. Inadequate sleep quantity and poor sleep quality have been shown to directly affect cognitive functioning and especially memory. The primary aim of the present study was to investigate the association of sleep quality with cognitive abilities cross-sectionally in a middle-aged Greek population and secondarily to examine this association prospectively in a smaller group of these participants.Patients and MethodsA total of 2112 healthy adults aged 25–70 years (mean: 46.7±11.5) from the Epirus Health Study cohort were included in the analysis and 312 of them participated in secondary prospective analysis. Sleep quality was measured by the Pittsburgh Sleep Quality Index (PSQI) scale and cognition was assessed in primary cross-sectional analyses with three neuropsychological tests, namely the Verbal Fluency test, the Logical …

Body size and risk of colorectal cancer molecular defined subtypes and pathways: Mendelian randomization analyses

Authors

Nikos Papadimitriou,Conghui Qu,Tabitha A Harrison,Alaina M Bever,Richard M Martin,Konstantinos K Tsilidis,Polly A Newcomb,Stephen N Thibodeau,Christina C Newton,Caroline Y Um,Mireia Obón-Santacana,Victor Moreno,Hermann Brenner,Marko Mandic,Jenny Chang-Claude,Michael Hoffmeister,Andrew J Pellatt,Robert E Schoen,Sophia Harlid,Shuji Ogino,Tomotaka Ugai,Daniel D Buchanan,Brigid M Lynch,Stephen B Gruber,Yin Cao,Li Hsu,Jeroen R Huyghe,Yi Lin,Robert S Steinfelder,Wei Sun,Bethany Van Guelpen,Syed H Zaidi,Amanda E Toland,Sonja I Berndt,Wen-Yi Huang,Elom K Aglago,David A Drew,Amy J French,Peter Georgeson,Marios Giannakis,Meredith Hullar,Johnathan A Nowak,Claire E Thomas,Loic Le Marchand,Iona Cheng,Steven Gallinger,Mark A Jenkins,Marc J Gunter,Peter T Campbell,Ulrike Peters,Mingyang Song,Amanda I Phipps,Neil Murphy

Journal

Ebiomedicine

Published Date

2024/3/1

BackgroundObesity has been positively associated with most molecular subtypes of colorectal cancer (CRC); however, the magnitude and the causality of these associations is uncertain.MethodsWe used Mendelian randomization (MR) to examine potential causal relationships between body size traits (body mass index [BMI], waist circumference, and body fat percentage) with risks of Jass classification types and individual subtypes of CRC (microsatellite instability [MSI] status, CpG island methylator phenotype [CIMP] status, BRAF and KRAS mutations). Summary data on tumour markers were obtained from two genetic consortia (CCFR, GECCO).FindingsA 1-standard deviation (SD:5.1 kg/m2) increment in BMI levels was found to increase risks of Jass type 1MSI-high,CIMP-high,BRAF-mutated,KRAS-wildtype (odds ratio [OR]: 2.14, 95% confidence interval [CI]: 1.46, 3.13; p-value = 9 × 10−5) and Jass type 2non …

Genome-wide association study and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancer

Authors

RS Laskar,C Qu,JR Huyghe,T Harrison,RB Hayes,Y Cao,PT Campbell,R Steinfelder,FR Talukdar,H Brenner,S Ogino,S Brendt,DT Bishop,DD Buchanan,AT Chan,M Cotterchio,SB Gruber,A Gsur,B van Guelpen,MA Jenkins,TO Keku,BM Lynch,L Le Marchand,RM Martin,K McCarthy,V Moreno,R Pearlman,M Song,KK Tsilidis,P Vodička,MO Woods,K Wu,L Hsu,MJ Gunter,U Peters,N Murphy,Colorectal Transdisciplinary CORECT Study,Colon Cancer Family Registry,Genetics and Epidemiology of Colorectal Cancer Consortium

Journal

Annals of Oncology

Published Date

2024/2/24

BackgroundThe incidence of early-onset colorectal cancer (EOCRC; diagnosed <50 years of age) is rising globally; however, the causes underlying this trend are largely unknown. Colorectal cancer (CRC) has strong genetic and environmental determinants, yet common genetic variants and causal modifiable risk factors underlying EOCRC are unknown. We conducted the first EOCRC-specific genome-wide association study (GWAS) and Mendelian randomization analyses to explore germline genetic and causal modifiable risk factors associated with EOCRC.Patients and methodsWe conducted a genome-wide association study meta-analysis of 6,176 EOCRC cases and 65,829 controls from Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Colorectal Transdisciplinary study (CORECT), Colon Cancer Family Registry (CCFR), and UK Biobank. We then used the EOCRC GWAS to investigate …

Genome-wide interaction study with smoking for colorectal cancer risk identifies novel genetic loci related to tumor suppression, inflammation and immune response

Authors

Robert Carreras-Torres,Andre E Kim,Yi Lin,Virginia Diez-Obrero,Stephanie A Bien,Conghui Qu,Jun Wang,Niki Dimou,Elom K Aglago,Emmanouil Bouras,Peter T Campbell,Graham Casey,Jenny Chang-Claude,David A Drew,Marc Gunter,Kristina M Jordahl,Eric Kawaguchi,Anshul Kundaje,John L Morrison,Neil Murphy,Polly Newcomb,Mireia Obon-Santacana,Nikos Papadimitriou,Anita R Peoples,Edward Ruiz-Narvaez,Anna Shcherbina,Mariana C Stern,Yu-Ru Su,Yu Tian,Konstantinos K Tsilidis,Franzel JB van Duijnhoven,Li Hsu,Ulrike Peters,Victor Moreno,W James Gauderman

Journal

Cancer Epidemiology, Biomarkers & Prevention

Published Date

2024/1/1

Background Tobacco smoking is an established risk factor for colorectal cancer. However, genetically defined population subgroups may have increased susceptibility to smoking-related effects on colorectal cancer. Methods A genome-wide interaction scan was performed including 33,756 colorectal cancer cases and 44,346 controls from three genetic consortia. Results Evidence of an interaction was observed between smoking status (ever vs. never smokers) and a locus on 3p12.1 (rs9880919, P = 4.58 × 10−8), with higher associated risk in subjects carrying the GG genotype [OR, 1.25; 95% confidence interval (CI), 1.20–1.30] compared with the other genotypes (OR <1.17 for GA and AA). Among ever smokers, we observed interactions between smoking intensity (increase in 10 cigarettes smoked per day) and two loci on 6p21.33 (rs4151657, P = 1.72 × …

Post-diagnosis adiposity and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis

Authors

N Becerra-Tomás,G Markozannes,M Cariolou,K Balducci,AR Vieira,S Kiss,D Aune,DC Greenwood,L Dossus,E Copson,AG Renehan,M Bours,W Demark-Wahnefried,M Hudson,AM May,FT Odedina,R Skinner,K Steindorf,A Tjonneland,G Velikova,ML Baskin,R Chowdhury,L Hill,S Lewis,J Seidell,M Weijenberg,J Krebs,A Cross,K Tsilidis,D Chan

Published Date

2024/1/17

Post-diagnosis adiposity and colorectal cancer prognosis: a Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis - White Rose Research Online White Rose logo White Rose Research Online Home Search Browse Contact Post-diagnosis adiposity and colorectal cancer prognosis: a Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis Becerra-Tomás, N., Markozannes, G., Cariolou, M. et al. (27 more authors) (Accepted: 2024) Post-diagnosis adiposity and colorectal cancer prognosis: a Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis. International Journal of Cancer. ISSN 0020-7136 (In Press) Metadata Authors/Creators: Becerra-Tomás, N. Markozannes, G. Cariolou, M. Balducci, K. Vieira, AR Kiss, S. Aune, D. Greenwood, DC ORCID logo https://orcid.org/0000-0001-7035-3096 …

Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes

Authors

Zhishan Chen,Xingyi Guo,Ran Tao,Jeroen R Huyghe,Philip J Law,Ceres Fernandez-Rozadilla,Jie Ping,Guochong Jia,Jirong Long,Chao Li,Quanhu Shen,Yuhan Xie,Maria N Timofeeva,Minta Thomas,Stephanie L Schmit,Virginia Díez-Obrero,Matthew Devall,Ferran Moratalla-Navarro,Juan Fernandez-Tajes,Claire Palles,Kitty Sherwood,Sarah EW Briggs,Victoria Svinti,Kevin Donnelly,Susan M Farrington,James Blackmur,Peter G Vaughan-Shaw,Xiao-Ou Shu,Yingchang Lu,Peter Broderick,James Studd,Tabitha A Harrison,David V Conti,Fredrick R Schumacher,Marilena Melas,Gad Rennert,Mireia Obón-Santacana,Vicente Martín-Sánchez,Jae Hwan Oh,Jeongseon Kim,Sun Ha Jee,Keum Ji Jung,Sun-Seog Kweon,Min-Ho Shin,Aesun Shin,Yoon-Ok Ahn,Dong-Hyun Kim,Isao Oze,Wanqing Wen,Keitaro Matsuo,Koichi Matsuda,Chizu Tanikawa,Zefang Ren,Yu-Tang Gao,Wei-Hua Jia,John L Hopper,Mark A Jenkins,Aung Ko Win,Rish K Pai,Jane C Figueiredo,Robert W Haile,Steven Gallinger,Michael O Woods,Polly A Newcomb,David Duggan,Jeremy P Cheadle,Richard Kaplan,Rachel Kerr,David Kerr,Iva Kirac,Jan Böhm,Jukka-Pekka Mecklin,Pekka Jousilahti,Paul Knekt,Lauri A Aaltonen,Harri Rissanen,Eero Pukkala,Johan G Eriksson,Tatiana Cajuso,Ulrika Hänninen,Johanna Kondelin,Kimmo Palin,Tomas Tanskanen,Laura Renkonen-Sinisalo,Satu Männistö,Demetrius Albanes,Stephanie J Weinstein,Edward Ruiz-Narvaez,Julie R Palmer,Daniel D Buchanan,Elizabeth A Platz,Kala Visvanathan,Cornelia M Ulrich,Erin Siegel,Stefanie Brezina,Andrea Gsur,Peter T Campbell,Jenny Chang-Claude,Michael Hoffmeister,Hermann Brenner,Martha L Slattery,John D Potter,Kostas K Tsilidis,Matthias B Schulze,Marc J Gunter,Neil Murphy,Antoni Castells,Sergi Castellví-Bel,Leticia Moreira,Volker Arndt,Anna Shcherbina,D Timothy Bishop,Graham G Giles,Melissa C Southey,Gregory E Idos,Kevin J McDonnell,Zomoroda Abu-Ful,Joel K Greenson,Katerina Shulman,Flavio Lejbkowicz,Kenneth Offit,Yu-Ru Su,Robert Steinfelder,Temitope O Keku,Bethany van Guelpen,Thomas J Hudson,Heather Hampel,Rachel Pearlman,Sonja I Berndt,Richard B Hayes,Marie Elena Martinez,Sushma S Thomas,Paul DP Pharoah,Susanna C Larsson,Yun Yen,Heinz-Josef Lenz,Emily White,Li Li,Kimberly F Doheny,Elizabeth Pugh,Tameka Shelford,Andrew T Chan,Marcia Cruz-Correa,Annika Lindblom,David J Hunter,Amit D Joshi,Clemens Schafmayer,Peter C Scacheri,Anshul Kundaje,Robert E Schoen

Journal

Nature Communications

Published Date

2024/4/26

Genome-wide association studies (GWAS) have identified more than 200 common genetic variants independently associated with colorectal cancer (CRC) risk, but the causal variants and target genes are mostly unknown. We sought to fine-map all known CRC risk loci using GWAS data from 100,204 cases and 154,587 controls of East Asian and European ancestry. Our stepwise conditional analyses revealed 238 independent association signals of CRC risk, each with a set of credible causal variants (CCVs), of which 28 signals had a single CCV. Our cis-eQTL/mQTL and colocalization analyses using colorectal tissue-specific transcriptome and methylome data separately from 1299 and 321 individuals, along with functional genomic investigation, uncovered 136 putative CRC susceptibility genes, including 56 genes not previously reported. Analyses of single-cell RNA-seq data from colorectal tissues revealed 17 …

Genome-Wide Gene–Environment Interaction Analyses to Understand the Relationship between Red Meat and Processed Meat Intake and Colorectal Cancer Risk

Authors

Mariana C Stern,Joel Sanchez Mendez,Andre E Kim,Mireia Obón-Santacana,Ferran Moratalla-Navarro,Vicente Martín,Victor Moreno,Yi Lin,Stephanie A Bien,Conghui Qu,Yu-Ru Su,Emily White,Tabitha A Harrison,Jeroen R Huyghe,Catherine M Tangen,Polly A Newcomb,Amanda I Phipps,Claire E Thomas,Eric S Kawaguchi,Juan Pablo Lewinger,John L Morrison,David V Conti,Jun Wang,Duncan C Thomas,Elizabeth A Platz,Kala Visvanathan,Temitope O Keku,Christina C Newton,Caroline Y Um,Anshul Kundaje,Anna Shcherbina,Neil Murphy,Marc J Gunter,Niki Dimou,Nikos Papadimitriou,Stéphane Bézieau,Franzel JB van Duijnhoven,Satu Männistö,Gad Rennert,Alicja Wolk,Michael Hoffmeister,Hermann Brenner,Jenny Chang-Claude,Yu Tian,Loïc Le Marchand,Michelle Cotterchio,Konstantinos K Tsilidis,D Timothy Bishop,Yohannes Adama Melaku,Brigid M Lynch,Daniel D Buchanan,Cornelia M Ulrich,Jennifer Ose,Anita R Peoples,Andrew J Pellatt,Li Li,Matthew AM Devall,Peter T Campbell,Demetrius Albanes,Stephanie J Weinstein,Sonja I Berndt,Stephen B Gruber,Edward Ruiz-Narvaez,Mingyang Song,Amit D Joshi,David A Drew,Jessica L Petrick,Andrew T Chan,Marios Giannakis,Ulrike Peters,Li Hsu,W James Gauderman

Journal

Cancer Epidemiology, Biomarkers & Prevention

Published Date

2024/3/1

Background High red meat and/or processed meat consumption are established colorectal cancer risk factors. We conducted a genome-wide gene–environment (GxE) interaction analysis to identify genetic variants that may modify these associations. Methods A pooled sample of 29,842 colorectal cancer cases and 39,635 controls of European ancestry from 27 studies were included. Quantiles for red meat and processed meat intake were constructed from harmonized questionnaire data. Genotyping arrays were imputed to the Haplotype Reference Consortium. Two-step EDGE and joint tests of GxE interaction were utilized in our genome-wide scan. Results Meta-analyses confirmed positive associations between increased consumption of red meat and processed meat with colorectal cancer risk [per quartile red meat OR = 1.30; 95% confidence interval …

Links between the genetic determinants of morning plasma cortisol and body shape: a two-sample Mendelian randomisation study

Authors

Sofia Christakoudi,Alexandros-Georgios Asimakopoulos,Elio Riboli,Konstantinos K Tsilidis

Journal

Scientific Reports

Published Date

2024/2/8

High cortisol production in Cushing’s syndrome leads to fat centralisation. The influence of modest cortisol variations on body shape, however, is less clear. We examined potentially causal associations between morning plasma cortisol and body shape and obesity with inverse-variance weighted random-effects models in a two-sample Mendelian randomisation analysis. We used publicly available summary statistics from the CORtisol NETwork (CORNET) consortium, UK Biobank, and the Genetic Investigation of Anthropometric Traits (GIANT) consortium. Only in women, morning plasma cortisol (proxied by ten genetic polymorphisms) was associated positively with waist size reflected in waist-to-hip index (WHI, 0.035 standard deviation (SD) units change per one SD cortisol increase; 95% confidence interval (0.002–0.067); p = 0.036) and “a body shape index” (ABSI; 0.039 (0.006–0.071); p = 0.021). There was …

A proteogenomic analysis of the adiposity colorectal cancer relationship identifies GREM1 as a probable mediator

Authors

Matthew A Lee,Charlie A Hatcher,Emma Hazelwood,Lucy J Goudswaard,Konstantinos K Tsilidis,Emma E Vincent,Richard M Martin,Karl Smith-Byrne,Hermann Brenner,Iona Cheng,Sun-Seog Kweon,Loic Le Marchand,Polly A Newcomb,Rovert E Schoen,Ulrike Peters,Marc J Gunter,Bethany Van Guelpen,Neil Murphy

Journal

medRxiv

Published Date

2024

Adiposity is an established risk factor for colorectal cancer (CRC). However, the pathways underlying this relationship, and specifically the role of the circulating proteome, is unclear. Utilizing two-sample Mendelian randomization and colocalization, based on summary data from large sex-combined and sex-specific genetic studies, we estimated the univariable (UV) associations between: (I) adiposity measures (body mass index, BMI; waist hip ratio, WHR) and overall and site-specific (colon, proximal colon, distal colon, and rectal) CRC risk, (II) adiposity measures and plasma proteins, and (III) adiposity-associated plasma proteins and CRC risk. We used multivariable MR (MVMR) to investigate the potential mediating role of adiposity- and CRC-related proteins in the adiposity-CRC association. BMI and WHR were positively associated with CRC risk, with similar associations by anatomical tumour site. 6,591 adiposity-protein (2,628 unique proteins) and 33 protein-CRC (8 unique proteins) associations were identified using UVMR and colocalization. 1 protein, GREM1 was associated with BMI only and CRC outcomes in a manner that was consistent with a potential mediating role in sex-combined and female-specific analyses. In MVMR, adjusting the BMI-CRC association for GREM1, effect estimates were attenuated - suggestive of a potential mediating role - most strongly for the BMI-overall CRC association in women. These results highlight the impact of adiposity on the plasma proteome and of adiposity-associated circulating proteins on the risk of CRC. Supported by evidence from cis-SNP UVMR and colocalization analyses, GREM1 was …

See List of Professors in Konstantinos (Kostas) K Tsilidis University(University of Ioannina)

Konstantinos (Kostas) K Tsilidis FAQs

What is Konstantinos (Kostas) K Tsilidis's h-index at University of Ioannina?

The h-index of Konstantinos (Kostas) K Tsilidis has been 54 since 2020 and 66 in total.

What are Konstantinos (Kostas) K Tsilidis's top articles?

The articles with the titles of

Leisure time television watching, computer use and risks of breast, colorectal and prostate cancer: A Mendelian randomisation analysis

Post-diagnosis physical activity and sedentary behaviour and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta …

Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis

Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk

Difference on glucose profile from continuous glucose monitoring in people with prediabetes vs. normoglycemic individuals: a matched-pair analysis

Interactions of obesity, body shape, diabetes and sex steroids with respect to prostate cancer risk in the UK Biobank cohort

Allometric versus traditional body-shape indices and risk of colorectal cancer: a Mendelian randomization analysis

Novel genetic loci, lifestyle factors, and inflammatory markers identified as risk factors for sarcoidosis

...

are the top articles of Konstantinos (Kostas) K Tsilidis at University of Ioannina.

What are Konstantinos (Kostas) K Tsilidis's research interests?

The research interests of Konstantinos (Kostas) K Tsilidis are: Cancer Epidemiology

What is Konstantinos (Kostas) K Tsilidis's total number of citations?

Konstantinos (Kostas) K Tsilidis has 16,167 citations in total.

What are the co-authors of Konstantinos (Kostas) K Tsilidis?

The co-authors of Konstantinos (Kostas) K Tsilidis are John P.A. Ioannidis, Ruth C. Travis, Sabine Rohrmann, Evangelos Evangelou, Ioanna Tzoulaki, Evangelia Ntzani, MD, PhD.

    Co-Authors

    H-index: 254
    John P.A. Ioannidis

    John P.A. Ioannidis

    Stanford University

    H-index: 106
    Ruth C. Travis

    Ruth C. Travis

    University of Oxford

    H-index: 93
    Sabine Rohrmann

    Sabine Rohrmann

    Universität Zürich

    H-index: 93
    Evangelos Evangelou

    Evangelos Evangelou

    University of Ioannina

    H-index: 89
    Ioanna Tzoulaki

    Ioanna Tzoulaki

    University of Ioannina

    H-index: 46
    Evangelia Ntzani, MD, PhD

    Evangelia Ntzani, MD, PhD

    University of Ioannina

    academic-engine

    Useful Links